Post Categories
Hacking the Nervous System to Improve Cancer Treatment
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the…
![graphic illustration of nervous system](https://www.qps.com/wp-content/uploads/2024/04/graphic-illustration-of-human-nervous-system-scaled.jpg)
Hacking the Nervous System to Improve Cancer Treatment
April 22, 2024
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the…
Oncology Drug Development: A Short History
Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel. The history of oncology…
![Patient entering CT scan](https://www.qps.com/wp-content/uploads/2024/04/Patient-entering-CT-scan-scaled.jpg)
Oncology Drug Development: A Short History
April 17, 2024
Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel. The history of oncology…
New Class of Weight Loss Drugs Shows Promise in Treating Heart Disease
NodThera, a biotech company based in Cambridge, England, is developing a new class of medicines that inhibit the NOD-, LRR- and pyrin domain-containing protein…
![Overweight senior man sitting outside with cane](https://www.qps.com/wp-content/uploads/2024/04/Overweight-senior-man-sitting-outside-with-cane-scaled.jpg)
New Class of Weight Loss Drugs Shows Promise in Treating Heart Disease
April 15, 2024
NodThera, a biotech company based in Cambridge, England, is developing a new class of medicines that inhibit the NOD-, LRR- and pyrin domain-containing protein…
COVID-19 Wiped Out a Flu Strain, Spurring Revamped Vaccine Strategy
Annual flu shots in the United States are going to be made a little differently this year, as one of the flu strains usually…
![Close-up of hand holding vaccine vial](https://www.qps.com/wp-content/uploads/2024/04/Close-up-of-hand-holding-vaccine-vial-scaled.jpg)
COVID-19 Wiped Out a Flu Strain, Spurring Revamped Vaccine Strategy
April 8, 2024
Annual flu shots in the United States are going to be made a little differently this year, as one of the flu strains usually…
Scientists Harness Brain Waves for Life-Changing Neuroprosthetics
Genetic abnormalities, neurodegenerative conditions, and trauma can all impact speech, making it difficult or impossible for those affected to communicate verbally. And while resources…
![Digital illustration of human brain with brain waves](https://www.qps.com/wp-content/uploads/2024/03/Digital-illustration-of-human-brain-with-brain-waves-scaled.jpg)
Scientists Harness Brain Waves for Life-Changing Neuroprosthetics
April 3, 2024
Genetic abnormalities, neurodegenerative conditions, and trauma can all impact speech, making it difficult or impossible for those affected to communicate verbally. And while resources…
Vivani Shifts to Weight Management with an Exenatide Implant
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani…
![Woman looking down at feet on scale](https://www.qps.com/wp-content/uploads/2024/04/Woman-looking-down-at-feet-on-scale-scaled.jpg)
Vivani Shifts to Weight Management with an Exenatide Implant
April 1, 2024
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani…
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
![CTIS Timeline Infographic](https://www.qps.com/wp-content/uploads/2023/04/Timeline-Infographic_v1_horizontal-V1_RGB-01-scaled.jpg)
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
March 20, 2024
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
![Happy young boy in wheelchair with his arms up](https://www.qps.com/wp-content/uploads/2024/03/Happy-young-boy-in-wheelchair-with-his-arms-up-scaled.jpg)
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
March 18, 2024
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
Navigating Changes to EU Clinical Trial Management: What You Need to Know
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
![European Medicines Agency Flag](https://www.qps.com/wp-content/uploads/2024/03/European-Medicines-Agency-Flag-scaled.jpg)
Navigating Changes to EU Clinical Trial Management: What You Need to Know
March 13, 2024
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
Psychoactive Drug Ibogaine Has Transformative Effects for Veterans with Traumatic Brain Injury
Traumatic brain injuries (TBIs), commonly experienced by military personnel, often incur deep damage and invisible scars. Such injuries are significant contributors to post-traumatic stress…
![Digital illustration of human brain on blue background](https://www.qps.com/wp-content/uploads/2024/03/Digital-illustration-of-human-brain-on-blue-background-scaled.jpg)
Psychoactive Drug Ibogaine Has Transformative Effects for Veterans with Traumatic Brain Injury
March 11, 2024
Traumatic brain injuries (TBIs), commonly experienced by military personnel, often incur deep damage and invisible scars. Such injuries are significant contributors to post-traumatic stress…
The Link Between Obesity Drugs and Brain Health
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in medical innovation. The drugs semaglutide and tirzepatide, known under brand names like Ozempic,…
![Man using injection pen, inserting into stomach](https://www.qps.com/wp-content/uploads/2024/03/Man-using-injection-pen-inserting-into-stomach-scaled.jpg)
The Link Between Obesity Drugs and Brain Health
March 6, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in medical innovation. The drugs semaglutide and tirzepatide, known under brand names like Ozempic,…
Advances in Treating Autoimmune Diseases Focus on Restoring Immune Tolerance
For decades, the battle against autoimmune diseases like type 1 diabetes, lupus, and multiple sclerosis has been an uphill struggle. Conventional treatments most often…
![Reddened hands of woman with Raynauds syndrome](https://www.qps.com/wp-content/uploads/2024/03/Reddened-hands-of-woman-with-Raynauds-syndrome-scaled.jpg)
Advances in Treating Autoimmune Diseases Focus on Restoring Immune Tolerance
March 4, 2024
For decades, the battle against autoimmune diseases like type 1 diabetes, lupus, and multiple sclerosis has been an uphill struggle. Conventional treatments most often…
mRNA Cancer Vaccine Shows Promise Against Glioblastoma
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed at the University of Florida (UF) has shown promise in treating patients with…
![Vaccine syringe and vial](https://www.qps.com/wp-content/uploads/2024/07/Vaccine-syringe-and-vial-scaled.jpg)
mRNA Cancer Vaccine Shows Promise Against Glioblastoma
July 8, 2024
In a pioneering first-in-human clinical trial, an mRNA cancer vaccine developed at the University of Florida (UF) has shown promise in treating patients with…
Cheating & Cooperating: How Viruses Communicate
Since their discovery in the late 1800s, viruses have been considered simple organisms largely incapable of communication. But today’s virologists have changed their tune;…
![Digital illustration of virus](https://www.qps.com/wp-content/uploads/2024/06/Digital-illustration-of-virus-scaled.jpg)
Cheating & Cooperating: How Viruses Communicate
June 19, 2024
Since their discovery in the late 1800s, viruses have been considered simple organisms largely incapable of communication. But today’s virologists have changed their tune;…
RNA Editing: A Safer Alternative in Genetic Medicine?
RNA editing is emerging as a promising and potentially safer alternative to therapies that modify an individual’s DNA. In December 2023, patients were treated…
![digital illustration of single strand of RNA](https://www.qps.com/wp-content/uploads/2024/06/digital-illustration-of-single-strand-of-RNA-scaled.jpg)
RNA Editing: A Safer Alternative in Genetic Medicine?
June 17, 2024
RNA editing is emerging as a promising and potentially safer alternative to therapies that modify an individual’s DNA. In December 2023, patients were treated…
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival…
![Digital illustration of human brain, one section highlighted pink indicating tumor](https://www.qps.com/wp-content/uploads/2024/06/Digital-illustration-of-human-brain-one-section-highlighted-pink-indicating-tumor-scaled.jpg)
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
June 13, 2024
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival…
The CAR-T Conundrum: Are Cutting-Edge Therapies Causing Cancer?
In November 2023, the U.S. Food and Drug Administration (FDA) announced an investigation into chimeric antigen receptor (CAR) T-cell therapies, questioning if these promising…
![digital illustration of DNA strand and scissors](https://www.qps.com/wp-content/uploads/2024/06/digital-illustration-of-DNA-strand-with-scissors-scaled.jpg)
The CAR-T Conundrum: Are Cutting-Edge Therapies Causing Cancer?
June 10, 2024
In November 2023, the U.S. Food and Drug Administration (FDA) announced an investigation into chimeric antigen receptor (CAR) T-cell therapies, questioning if these promising…
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk…
![Needle beneath red no symbol](https://www.qps.com/wp-content/uploads/2024/06/Needle-beneath-red-no-symbol-scaled.jpg)
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
June 3, 2024
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…